Stockreport

Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research

Fluidigm Corporation  (FLDM) 
Last fluidigm corporation earnings: 2/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.fluidigm.com
PDF SOUTH SAN FRANCISCO, Calif., July 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the launch of the Advanta™ Immuno-Oncology Gene Expre [Read more]